Renewal of Provisional Consent to the Distribution of a New Medicine
In the notice published in the New Zealand Gazette,
27 August 1998, Issue No. 125, page 3032, notice No. 6092 for Codalax oral suspension add between lines 11 and 12, and for Codalax Forte oral suspension add between lines
16 and 17 Condition: This medicine may only be used for the prevention or treatment of constipation in the terminally ill.
Dated this 8th day of March 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.